HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017
The Lancet Gastroenterology & Hepatology in conversation with - Un podcast de The Lancet Group
Catégories:
Federico Aucejo talks about his HALT-HCC score, which assesses risk for patients with hepatocellular carcinoma awaiting liver transplant. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
